Ads
related to: mode of inheritance huntington's disease- About HD Chorea
Learn About Chorea & the Importance
of Treating Early.
- Starting Patients
Getting Your Patients Started
on Treatment for HD Chorea.
- Cost & Coverage Support
Learn About Cost & Coverage Support
for Your Patients with HD Chorea.
- Shared Solutions
Learn More About Teva Shared
Solutions for Your Patients.
- HD Clinical Trial Results
Review Pivotal Study Results
for Huntington's Disease Chorea.
- Polypharmacy
See Polypharmacy Info
for This HD Chorea Treatment.
- About HD Chorea
Search results
Results From The WOW.Com Content Network
Huntington's disease has autosomal dominant inheritance, meaning that an affected individual typically inherits one copy of the gene with an expanded trinucleotide repeat (the mutant allele) from an affected parent. [26] Since the penetrance of the mutation is very high, those who have a mutated copy of the gene will have the disease.
This is the case for Huntington's disease, where the trinucleotide repeat encodes a long stretch of glutamine residues. When the repeat is present in an untranslated region, it could affect the expression of the gene in which the repeat is found (ex. fragile X ) or many genes through a dominant negative effect (ex. myotonic dystrophy ).
Huntingtin (Htt) is the protein coded for in humans by the HTT gene, also known as the IT15 ("interesting transcript 15") gene. [5] Mutated HTT is the cause of Huntington's disease (HD), and has been investigated for this role and also for its involvement in long-term memory storage.
Most genetic disorders are diagnosed pre-birth, at birth, or during early childhood however some, such as Huntington's disease, can escape detection until the patient begins exhibiting symptoms well into adulthood. [35] The basic aspects of a genetic disorder rests on the inheritance of genetic material.
SMBA is the first "CAG / polygutamine" disease, which is a subcategory of repeat disorders. [9] In 1992, for myotonic dystrophy type 1 (DM1), CTG expansion was found in the myotonic dystrophy protein kinase (DMPK) 3' UTR. In 1993, for Huntington's disease (HD), a longer-than-usual CAG repeat with was found in the exon 1 coding sequence. [10]
These often are translated into polyglutamine-containing proteins that form inclusions and are toxic to neuronal cells. Examples of the disorders caused by this mechanism include Huntington's disease and Huntington disease-like 2, spinal-bulbar muscular atrophy, dentatorubral-pallidoluysian atrophy, and spinocerebellar ataxia 1–3, 6–8, and 17.
Ad
related to: mode of inheritance huntington's disease